We are live on ! Find out more
BCM

Brookmont Capital Management Portfolio holdings

AUM $186M
1-Year Est. Return 10.11%
This Fund
S&P 500
This Quarter Est. Return
-0.9%
1 Year Est. Return
+10.11%
3 Year Est. Return
+36.63%
5 Year Est. Return
+48.26%
10 Year Est. Return
+211.29%
AUM
$177M
AUM Growth
-$9.86M
Cap. Flow
-$6.71M
Cap. Flow %
-3.78%
Top 10 Hldgs %
57.92%
Holding
54
New
Increased
6
Reduced
46
Closed
1

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$1.1M
2
NVDA icon
NVIDIA
NVDA
+$15.2K
3
BWXT icon
BWX Technologies
BWXT
+$3.36K
4
DIS icon
Walt Disney
DIS
+$3.22K
5
AVGO icon
Broadcom
AVGO
+$212

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$1.3M
2
WFC icon
Wells Fargo
WFC
+$635K
3
JPM icon
JPMorgan Chase
JPM
+$513K
4
AJG icon
Arthur J. Gallagher & Co
AJG
+$395K
5
ABT icon
Abbott
ABT
+$354K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.37%
2 Financials 13.55%
3 Healthcare 12.1%
4 Technology 7.72%
5 Industrials 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWD icon
51
iShares Russell 1000 Value ETF
IWD
$83.9B
$215K 0.12%
1,144
AAPL icon
52
Apple
AAPL
$4.57T
$214K 0.12%
966
-99
-9% -$22.9K
AVGO icon
53
Broadcom
AVGO
$2.04T
$200K 0.11%
1,197
+1
+0.1% +$212
LOW icon
54
Lowe's Companies
LOW
$125B
-883
Closed -$218K

Similar funds

Brookmont Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Brookmont Capital Management held 54 positions worth $177M, down 5.3% from $187M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Brookmont Capital Management withdrew a net $6.71M in Q1 2025, closing 1 position and reducing 46 holdings. Its most notable exit was Lowe's Companies, an estimated $218K position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 36% of assets, down from 37% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Brookmont Capital Management added an estimated $1.1M to Novo Nordisk.

  • Brookmont Capital Management added most to Novo Nordisk in Q1 2025, an estimated $1.1M increase.
  • Brookmont Capital Management's biggest Q1 2025 reduction was Gilead Sciences, cutting an estimated $1.3M.
  • Brookmont Capital Management fully exited Lowe's Companies in Q1 2025, selling an estimated $218K.
  • Brookmont Capital Management's ten largest holdings make up 58% of its $177M portfolio in Q1 2025.
  • Brookmont Capital Management opened 0 new positions and closed 1 in Q1 2025.
  • Brookmont Capital Management's portfolio value fell 5.3% quarter-over-quarter to $177M.

Based on Brookmont Capital Management's 13F filing for Q1 2025, filed 12 May 2025.